age-related plasma decline (roughly 200 ng/mL at age 20 to about 80 ng/mL by 60): Pickart L, Margolina A
This medication can also be beneficial for individuals with specific underlying medical conditions contributing to weight gain, such as Cushings syndrome, hypothyroidism, or certain genetic disorders
The American Diabetes Association guidelines emphasize that neuropathic symptoms in diabetic patients are far more commonly related to glycemic control history and diabetes duration than to specific glucose-lowering medications
In a large study published in the New England Journal of Medicine, Semaglutide (which is the active ingredient in both Ozempic) led to an average weight loss of about 15% of the body weight in about a year, which is an average total weight loss of about 33.7 lbs
NICE guidelines suggest reassessing after 6 months, with continued prescription only if youve lost at least 5% of your starting weight
This matters more than you'd think when you're navigating the adjustment period